Combination Therapy and the Start of a New Epoch for Idiopathic Pulmonary Fibrosis?
- PMID: 28984465
- DOI: 10.1164/rccm.201709-1939ED
Combination Therapy and the Start of a New Epoch for Idiopathic Pulmonary Fibrosis?
Comment on
-
Nintedanib with Add-on Pirfenidone in Idiopathic Pulmonary Fibrosis. Results of the INJOURNEY Trial.Am J Respir Crit Care Med. 2018 Feb 1;197(3):356-363. doi: 10.1164/rccm.201706-1301OC. Am J Respir Crit Care Med. 2018. PMID: 28889759 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
